Sihuan Pharmaceutical Holdings Group Ltd. (SIHUAN PHARM) released formal notice that its Interim Report 2026 is now available on the company’s website and on HKExnews. Shareholders can access the document by selecting “Investor Relations” and then “Financial & ESG Reports” on www.sihuanpharm.com, or by visiting www.hkexnews.hk.

The company reiterated that investors may choose their preferred format—electronic or printed—and language version (English, Chinese, or both) for all future corporate communications. To modify an existing preference, shareholders should submit the enclosed Change Request Form to Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Changes can also be requested via email at sihuanpharm-ecom@vistra.com.

In cases where electronic access proves difficult, shareholders are entitled to receive printed copies of the interim report free of charge upon request. For further assistance, Tricor’s hotline is available on business days from 9:00 a.m. to 5:00 p.m. at (852) 2980 1333.

The notice was authorised by Chairman and Executive Director Dr. Che Fengsheng on 17 September 2026.